Characterization and outcomes of young infants with acute liver failure

Shikha S Sundaram1, Estella M Alonso, Michael R Narkewicz

  • 1Department of Pediatrics, Section of Gastroenterology, Hepatology and Nutrition, The Children's Hospital, University of Colorado School of Medicine, Aurora, CO, USA. sundaram.shikha@tchden.org

Insights

Acute liver failure (ALF) in infants under 90 days shows better spontaneous survival than expected. Liver transplantation offers a viable option for infants with ALF, especially those with indeterminate or viral causes.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Neonatal Medicine

Background:

  • Acute liver failure (ALF) in infants presents significant diagnostic and management challenges.
  • Understanding the specific characteristics and outcomes of ALF in neonates and young infants is crucial for improving care.

Purpose of the Study:

  • To characterize the clinical presentation, etiologies, and outcomes of infants aged 90 days or younger with acute liver failure.
  • To analyze survival rates and the role of liver transplantation in this vulnerable population.

Main Methods:

  • Analysis of prospective data from the international, multicenter Pediatric Acute Liver Failure (PALF) Study Group.
  • Inclusion of infants aged ≤ 90 days enrolled in the registry before May 18, 2009.

Main Results:

  • 148 infants with ALF were identified, with a median age of 18 days.
  • Common etiologies included indeterminate causes (38%), neonatal hemochromatosis (13.6%), and herpes simplex virus (12.8%).
  • Spontaneous survival was observed in 60% of infants, 16% received liver transplants, and 24% died without transplantation. Infants with indeterminate ALF had higher rates of liver transplantation compared to viral-induced ALF. Viral ALF was associated with a significantly higher cumulative incidence of death without transplantation.

Conclusions:

  • Acute liver failure in young infants has distinct diagnostic considerations.
  • Spontaneous survival rates for ALF in this age group are more favorable than previously reported.
  • Liver transplantation serves as an important therapeutic option for infants with ALF, improving overall management and outcomes.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...